The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
181
Research Facility
Huntsville, Alabama, United States
Research Facility
Los Angeles, California, United States
Research Facility
San Diego, California, United States
Percentage of Subjects With a Greater Than or Equal to 50% Decrease in Sperm Concentration From Baseline to Week 26
Subjects provided 2 semen samples at each visit 2 to 12 days apart. The average value is used as the visit result.
Time frame: Baseline to Week 26
Percentage of Subjects With Greater Than or Equal to 50% Reduction in Sperm Count From Baseline to Week 26
Time frame: baseline to week 26
Percentage of Subjects With Greater Than or Equal to 50% Reduction in Sperm Motility From Baseline to Week 26
Sperm motility was based upon the WHO grading scale: grade A, B, or C.
Time frame: baseline to week 26
Percentage of Subjects With Greater Than or Equal to 50% Reduction in Semen Volume From Baseline to Week 26
Time frame: baseline to week 26
Percentage of Subjects With Greater Than or Equal to 50% Reduction in Normal Sperm Morphology From Baseline to Week 26
Time frame: baseline to week 26
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Facility
Parker, Colorado, United States
Research Facility
Aventura, Florida, United States
Research Facility
Carmel, Indiana, United States
Research Facility
New Orleans, Louisiana, United States
Research Facility
Shreveport, Louisiana, United States
Research Facility
Kansas City, Missouri, United States
Research Facility
Albany, New York, United States
...and 5 more locations